US equities
|
NVDA
$204.64
▼-4.22%
INTC
$65.76
▼-28.58%
MU
$884.74
▼-5.30%
AMZN
$240.35
▼-1.41%
AAPL
$344.63
▼-1.23%
SNDK
$1,150.89
▼-13.47%
AMD
$504.80
▼-10.88%
MSFT
$521.91
▼-1.55%
NVDA
$204.64
▼-4.22%
INTC
$65.76
▼-28.58%
MU
$884.74
▼-5.30%
AMZN
$240.35
▼-1.41%
AAPL
$344.63
▼-1.23%
SNDK
$1,150.89
▼-13.47%
AMD
$504.80
▼-10.88%
MSFT
$521.91
▼-1.55%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Ligand Pharmaceuticals Incorporated - Common Stock
(NQ:
LGND
)
322.75
+5.42 (+1.71%)
Delayed Quote
Updated: 4:00 PM EDT, Oct 30, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Ligand Pharmaceuticals Incorporated - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
Next >
The Daily Biotech Pulse: Vaxart Rebounds On Strong Vaccine Data, Pfizer's Beat-And-Raise Quarter, BioLineRx Data
↗
May 04, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 3) AbbVie Inc. (NYSE: ABBV)...
Via
Benzinga
Ligand's Revenue Soars in Q1 Thanks to Gilead's COVID Drug
↗
May 04, 2021
The drugmaker is also looking for its highest sales ever in 2021 in large part because of remdesivir.
Via
The Motley Fool
Ligand Pharmaceuticals Inc (LGND) Q1 2021 Earnings Call Transcript
↗
May 04, 2021
LGND earnings call for the period ending March 31, 2021.
Via
The Motley Fool
Topics
Earnings
12 Health Care Stocks Moving In Monday's After-Market Session
↗
May 03, 2021
Gainers Precipio (NASDAQ:
Via
Benzinga
Recap: Ligand Pharmaceuticals Q1 Earnings
↗
May 03, 2021
Shares of Ligand Pharmaceuticals (NASDAQ:LGND) fell 7% in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share were up 58.43% over the...
Via
Benzinga
Ligand Reports First Quarter 2021 Financial Results
May 03, 2021
From
Ligand Pharmaceuticals Incorporated
Via
Business Wire
Earnings Scheduled For May 3, 2021
↗
May 03, 2021
Companies Reporting Before The Bell • Scienjoy Holding (NASDAQ:SJ) is estimated to report quarterly earnings at $0.58 per share on revenue of $540.11 million. •...
Via
Benzinga
Short Interest Report: B&G Foods Short Position At Three-Month Highs
↗
April 30, 2021
Estimated short interest in B&G Foods has accelerated its gains, spiking on Monday and also rising for four out of five trading sessions. For the week, B&G Foods short interest was up 22% at 28.94% of...
Via
Talk Markets
Ligand to Report First Quarter Financial Results on May 3, 2021
April 22, 2021
From
Ligand Pharmaceuticals Incorporated
Via
Business Wire
3 Signs the Ligand Short Squeeze Is Over
↗
April 22, 2021
The Reddit crowd wasn't the only reason short-sellers got burned betting against this pharmaceutical company.
Via
The Motley Fool
< Previous
1
2
3
4
5
6
7
8
9
Next >